Crystallization of Microparticulate Pure Polymorphs of Active Pharmaceutical Ingredients Using CO 2 -Expanded Solvents

The feasibility of the Depressurization of an Expanded Liquid Organic Solution (DELOS) method to process different active pharmaceutical ingredients (APIs) as finely divided powders with narrow particle size distribution, high crystallinity degree, high polymorphic purity, and free from residual sol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Crystal growth & design 2012-04, Vol.12 (4), p.1717-1726
Hauptverfasser: Sala, Santiago, Córdoba, Alba, Moreno-Calvo, Evelyn, Elizondo, Elisa, Muntó, Maria, Rojas, Paula Elena, Larrayoz, Maria Àngels, Ventosa, Nora, Veciana, Jaume
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The feasibility of the Depressurization of an Expanded Liquid Organic Solution (DELOS) method to process different active pharmaceutical ingredients (APIs) as finely divided powders with narrow particle size distribution, high crystallinity degree, high polymorphic purity, and free from residual solvent has been demonstrated. Cholesterol, acetylsalicylic acid (aspirin), naproxen, acetaminophen, and ibuprofen were chosen as model drugs. It has been demonstrated that the supersaturation ratio attained during crystallization from CO2-expanded solvents can be modulated through appropriate variations of process parameters  CO2 content and concentration of the initial solution. In view of the potential application that compressed fluidsbased technologies have in the pharmaceutical industry, a preliminary scalability study of the process in compliance with the constraints imposed by the Good Manufacturing Practices (GMP) specifications is presented herein Peer Reviewed
ISSN:1528-7483
1528-7505
DOI:10.1021/cg200356x